+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cord Blood Product Market - Global Forecast 2025-2030- Product Image
Cord Blood Product Market - Global Forecast 2025-2030- Product Image
Sale

Cord Blood Product Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6143864
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Exploring the Vital Role of Cord Blood Products in Pioneering Modern Therapeutic Paradigms Across Regenerative and Clinical Applications

Over the past decade, cord blood products have transcended their initial role as a niche source of hematopoietic stem cells to become integral elements of both established and emerging therapeutic strategies. Advances in stem cell biology have validated the regenerative potential of cord blood and cord tissue units, spawning a wave of novel applications that range from hematopoietic disorder treatments to cutting-edge immunotherapies. Concurrently, improvements in collection, processing, and storage methodologies have enhanced product quality and consistency, enabling more reliable outcomes in clinical and research settings.

This executive summary distills the key findings from a rigorous analysis of the global cord blood products landscape. It outlines transformative shifts in technology and regulation, examines the repercussions of new trade measures, and highlights the differentiated drivers emerging from intricate segmentation across products, applications, end users, and payment modes. Readers will gain a nuanced understanding of regional variances, strategic moves by leading industry participants, and a set of pragmatic recommendations geared toward fostering sustainable growth.

Charting the Evolution of Cord Blood Therapies as Innovations in Processing, Genomic Profiling, and Regulatory Frameworks Reshape the Healthcare Ecosystem

The cord blood sector is undergoing a profound metamorphosis fueled by rapid technological breakthroughs and evolving regulatory frameworks. Innovations in automated processing platforms and closed-system storage solutions are significantly reducing contamination risks and enhancing cell viability, thereby elevating the standard of clinical-grade units. Meanwhile, integration of genomic profiling techniques is enabling more precise donor-recipient matching and personalized therapy design, unlocking new possibilities in immunotherapy and regenerative medicine.

Regulators across major markets have responded to these developments by issuing updated guidelines that seek to harmonize quality control measures and expedite approval pathways for advanced cell-based treatments. Concurrently, growing investments in R&D by biotechnology firms and academic institutions are driving the discovery of novel applications, ranging from neurodegenerative conditions to metabolic disorders. As these shifts converge, the market is poised to transition from a predominantly diagnostic and supportive role toward a central pillar in next-generation therapeutic protocols.

Assessing the Cumulative Impact of New Tariff Regimes on Cord Blood Supply Chains and Cost Structures Amid Shifting Global Trade Policies in 2025

The implementation of targeted tariffs on imported medical equipment and reagents in early 2025 has introduced fresh complexities into the global cord blood supply chain. Organizations that rely on specialized instruments and consumables sourced from overseas have encountered increased procurement costs, and volatility in price structures has prompted many to reevaluate supplier portfolios. Even facilities that manufacture domestically have felt ripple effects as upstream suppliers adjust their own pricing in response to shifting trade economics.

In parallel, new duty structures have spurred efforts to localize critical production steps, driving investments in domestic processing laboratories and incentivizing partnerships between regional biobanks and component manufacturers. While these initiatives help to mitigate the immediate impact of elevated import costs, they also demand substantial capital outlays and operational realignment. As a result, industry stakeholders must navigate a delicate balance between sustaining affordability for end users and preserving the rigorous quality standards essential for clinical and research applications.

Unlocking In-Depth Market Perspectives Through Detailed Segmentation of Products, Applications, End Users, and Payment Modes Shaping Growth Dynamics

A comprehensive examination of market segmentation reveals that cord blood offerings can be categorized by product type into three principal areas: banking services that encompass the collection, processing, and storage of biological materials; cord blood units differentiated into clinical grade and research grade; and cord tissue units similarly subdivided into clinical and research classifications. Each subcategory addresses unique quality requirements and end-user expectations, positioning providers to tailor solutions based on therapeutic or investigational objectives.

From an application standpoint, the landscape bifurcates into allogeneic therapy, which primarily addresses hematopoietic and immune disorders, and autologous therapy, which focuses on regenerative medicine and supportive therapies aimed at individual patient care. End users reflect a diverse mix of hospitals and clinics that administer treatments directly, pharmaceutical companies developing proprietary therapies, and research institutes conducting foundational studies. Payment models further shape adoption, with private banking services appealing to families seeking exclusive access to stored units and public banking initiatives facilitating broader community benefit. This layered segmentation underscores the multifaceted dynamics at play, illustrating how product attributes, clinical intent, user requirements, and financial structures collectively influence market trajectories.

Navigating Regional Variances Across the Americas, Europe Middle East Africa, and Asia-Pacific to Uncover Distinct Demand Drivers and Infrastructure Strengths

Regional analysis highlights stark contrasts in infrastructure maturity, regulatory oversight, and patient awareness across the Americas, Europe Middle East Africa, and Asia-Pacific. In the Americas, well-established public cord blood banks coexist with a robust network of private storage services, supported by government incentives and a culture of proactive investment in advanced healthcare solutions. This blend has accelerated adoption of novel therapies and facilitated high-volume clinical trials.

Europe, the Middle East, and Africa present a mosaic of regulatory frameworks that vary from stringent harmonized guidance in the European Union to emerging policies in Middle Eastern states aimed at positioning their healthcare sectors as regional hubs. Africa’s nascent facilities are beginning to benefit from international collaborations that aim to enhance processing capabilities and improve access. Meanwhile, Asia-Pacific is experiencing rapid growth driven by rising newborn volumes, supportive reimbursement policies, and burgeoning biopharma partnerships. As a result, key markets in East Asia and Southeast Asia are shifting from service importation to localized production and innovation.

Profiling Key Industry Leaders in Cord Blood Banking and Therapeutics Highlighting Strategic Investments, Partnerships, and Innovations Enabling Market Leadership

Leading players in the cord blood domain are continually refining their strategic playbooks to capture evolving opportunities. Some have prioritized expansion of collection networks by forging alliances with maternity hospitals and obstetric clinics, thereby securing a reliable pipeline of donations. Others are channeling resources into proprietary processing technologies that aim to maximize stem cell yield and viability. Strategic partnerships between biobanks and therapy developers are increasingly common, designed to accelerate translational research and clinical trial enrollment.

Furthermore, corporate R&D investments are directed toward novel cryopreservation techniques, ex vivo expansion platforms, and combination products that integrate cord-derived cells with biomaterials or small molecules. In parallel, digital platforms that streamline donor registration, sample tracking, and regulatory documentation are enhancing operational transparency and compliance. As competitive pressures intensify, organizations that cultivate a balanced portfolio of service excellence, technological differentiation, and collaborative ecosystems are best positioned to secure a leading role in the next chapter of cord blood innovation.

Formulating Actionable Strategies for Industry Stakeholders to Capitalize on Emerging Opportunities and Address Critical Challenges in Cord Blood Markets

Industry stakeholders can capitalize on the current inflection point by prioritizing investments in cutting-edge processing and storage technologies that offer demonstrable improvements in cell viability and therapeutic efficacy. Strengthening relationships with regional healthcare providers through comprehensive education programs and streamlined integration protocols will foster broader acceptance of cord blood therapies. At the same time, cultivating alliances with diagnostic and pharmaceutical entities can accelerate the translation of research-grade units into viable clinical products.

Given the complexities introduced by recent tariff adjustments, diversifying supply chains to include both local and international sources will enhance resilience and protect against cost volatility. Embracing scalable digital solutions for inventory management and regulatory reporting will reduce administrative burdens and ensure alignment with emerging global standards. Finally, aligning product offerings with evolving reimbursement paradigms-particularly in markets that are expanding public banking initiatives-will unlock new patient segments and reinforce the long-term sustainability of cord blood services.

Detailing Rigorous Research Methodologies Combining Qualitative and Quantitative Approaches for Robust Intelligence on Cord Blood Industry Dynamics

This analysis is grounded in a multi-faceted research methodology that combines extensive secondary research, primary interviews with subject matter experts, and rigorous data triangulation. The secondary research phase involved a systematic review of scientific literature, patent filings, regulatory publications, and industry white papers to map technological advancements and policy trends. In parallel, primary data was collected through interviews with executives from biobanks, therapy developers, regulatory authorities, and key opinion leaders, ensuring a robust understanding of real-world operational dynamics.

Quantitative insights were derived from an aggregated evaluation of public disclosures, financial filings, and clinical trial registries to profile competitive positioning and investment patterns. Qualitative analysis drew upon thematic coding and cross-validation techniques to distill nuanced perspectives on customer preferences and adoption barriers. The entire process adhered to strict quality control measures, including multiple rounds of expert review and methodological cross-checks, to guarantee the accuracy, relevance, and completeness of the insights presented.

Synthesizing Principal Market Insights to Illuminate Critical Themes, Opportunities, and Pathways Forward in the Evolving Cord Blood Sector

In synthesizing the core findings, it becomes evident that the cord blood sector is at a pivotal juncture defined by accelerating technological innovation, shifting trade dynamics, and complex regulatory landscapes. Segmentation analysis reveals that product diversity, therapeutic intent, end-user profiles, and payment frameworks interact in intricate ways to shape growth trajectories. Regional disparities offer both challenges and opportunities, with mature markets emphasizing service optimization and emerging regions driving capacity expansion.

Leading companies are leveraging strategic partnerships, proprietary process improvements, and digital solutions to maintain competitiveness and foster new therapeutic pathways. However, the imposition of new tariffs underscores the necessity for supply chain agility and cost management. By embracing the recommended actions-ranging from technology investments to collaborative alliances-industry participants can reinforce their market positions, meet evolving clinical needs, and unlock the full potential of cord blood therapies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Cord Blood Banking Services
      • Collection Services
      • Processing Services
      • Storage Services
    • Cord Blood Units
      • Clinical Grade Units
      • Research Grade Units
    • Cord Tissue Units
      • Clinical Grade Units
      • Research Grade Units
  • Application
    • Allogeneic Therapy
      • Hematopoietic Disorders
      • Immune Disorders
    • Autologous Therapy
      • Regenerative Medicine
      • Supportive Therapies
  • End User
    • Hospitals & Clinics
    • Pharmaceutical Companies
    • Research Institutes
  • Payment Mode
    • Private Banking
    • Public Banking
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • CBR Systems, Inc.
  • ViaCord, LLC
  • Cryo-Cell International, Inc.
  • China Cord Blood Corporation
  • Cordlife Group Limited
  • Americord Registry, LLC
  • LifeCell International Pvt. Ltd.
  • Cells4Life Group Limited
  • StemCyte, Inc.
  • European Cord Blood Bank, S.L.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising investment in cord blood banking infrastructure driven by expanding newborn enrollment rates
5.2. Increased regulatory approvals for cord blood-derived cellular therapies boosting treatment accessibility
5.3. Strategic partnerships between biotech firms and fertility clinics to expand cord blood collection networks
5.4. Advancements in automated cord blood processing technologies enabling higher stem cell viability rates
5.5. Growing consumer awareness of private versus public cord blood banking influencing storage subscription trends
5.6. Emerging evidence of cord blood applications in neurodegenerative disease trials sparking research funding surges
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cord Blood Product Market, by Product Type
8.1. Introduction
8.2. Cord Blood Banking Services
8.2.1. Collection Services
8.2.2. Processing Services
8.2.3. Storage Services
8.3. Cord Blood Units
8.3.1. Clinical Grade Units
8.3.2. Research Grade Units
8.4. Cord Tissue Units
8.4.1. Clinical Grade Units
8.4.2. Research Grade Units
9. Cord Blood Product Market, by Application
9.1. Introduction
9.2. Allogeneic Therapy
9.2.1. Hematopoietic Disorders
9.2.2. Immune Disorders
9.3. Autologous Therapy
9.3.1. Regenerative Medicine
9.3.2. Supportive Therapies
10. Cord Blood Product Market, by End User
10.1. Introduction
10.2. Hospitals & Clinics
10.3. Pharmaceutical Companies
10.4. Research Institutes
11. Cord Blood Product Market, by Payment Mode
11.1. Introduction
11.2. Private Banking
11.3. Public Banking
12. Americas Cord Blood Product Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cord Blood Product Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cord Blood Product Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. CBR Systems, Inc.
15.3.2. ViaCord, LLC
15.3.3. Cryo-Cell International, Inc.
15.3.4. China Cord Blood Corporation
15.3.5. Cordlife Group Limited
15.3.6. Americord Registry, LLC
15.3.7. LifeCell International Pvt. Ltd.
15.3.8. Cells4Life Group Limited
15.3.9. StemCyte, Inc.
15.3.10. European Cord Blood Bank, S.L.
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. CORD BLOOD PRODUCT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CORD BLOOD PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CORD BLOOD PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CORD BLOOD PRODUCT MARKET: RESEARCHAI
FIGURE 24. CORD BLOOD PRODUCT MARKET: RESEARCHSTATISTICS
FIGURE 25. CORD BLOOD PRODUCT MARKET: RESEARCHCONTACTS
FIGURE 26. CORD BLOOD PRODUCT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CORD BLOOD PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY COLLECTION SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY COLLECTION SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PROCESSING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PROCESSING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY STORAGE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CLINICAL GRADE UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CLINICAL GRADE UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY RESEARCH GRADE UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY RESEARCH GRADE UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CLINICAL GRADE UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CLINICAL GRADE UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY RESEARCH GRADE UNITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY RESEARCH GRADE UNITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY HEMATOPOIETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY HEMATOPOIETIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY IMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY IMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY SUPPORTIVE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY SUPPORTIVE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PRIVATE BANKING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PRIVATE BANKING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PUBLIC BANKING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CORD BLOOD PRODUCT MARKET SIZE, BY PUBLIC BANKING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CORD BLOOD PRODUCT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 112. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 113. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 114. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 115. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 116. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 117. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 118. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 119. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 120. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 121. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 122. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 123. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 126. CANADA CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 144. MEXICO CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA CORD BLOOD PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 225. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 226. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 227. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 230. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 231. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 232. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 233. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 236. GERMANY CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 241. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 242. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 243. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 244. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 245. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 248. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 249. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 250. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 251. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 254. FRANCE CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 266. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 273. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 276. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 277. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 278. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 279. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 280. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 281. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 284. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 285. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 286. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 287. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 290. ITALY CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 291. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 292. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 293. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 294. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 295. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 296. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 297. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 298. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 299. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 302. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 303. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 304. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 305. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 308. SPAIN CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2018-2024 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY CORD TISSUE UNITS, 2025-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2018-2024 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY ALLOGENEIC THERAPY, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY AUTOLOGOUS THERAPY, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES CORD BLOOD PRODUCT MARKET SIZE, BY PAYMENT MODE, 2025-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. SAUDI ARABIA CORD BLOOD PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2018-2024 (USD MILLION)
TABLE 330. SAUDI ARABIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD BANKING SERVICES, 2025-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2018-2024 (USD MILLION)
TABLE 332. SAUDI ARABIA CORD BLOOD PRODUCT MARKET SIZE, BY CORD BLOOD UNITS, 2025-2030 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cord Blood Product Market report include:
  • CBR Systems, Inc.
  • ViaCord, LLC
  • Cryo-Cell International, Inc.
  • China Cord Blood Corporation
  • Cordlife Group Limited
  • Americord Registry, LLC
  • LifeCell International Pvt. Ltd.
  • Cells4Life Group Limited
  • StemCyte, Inc.
  • European Cord Blood Bank, S.L.

Related Topics

Related Reports

Cord Blood Banking Services Market - Global Forecast 2025-2030 - Product Image

Cord Blood Banking Services Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Umbilical Cord Blood Processing Products Market - Global Forecast 2025-2030 - Product Image

Umbilical Cord Blood Processing Products Market - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024 - Product Image

Global Cord Blood & Tissue Banking Industry Report - Market Size, Segmentation, & Forecasts, 2024

  • Report
  • 296 Pages
  • Global
From
Cord Blood Bank Services - Global Strategic Business Report - Product Image

Cord Blood Bank Services - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Stem Cell Umbilical Cord Blood - Global Strategic Business Report - Product Image

Stem Cell Umbilical Cord Blood - Global Strategic Business Report

  • Report
  • 127 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.